نتائج البحث 1041-1050 من 4989 لعملية البحث عن Blood factor II
Patients will complete dietary questionnaire and have research blood ... This is a phase II multi-center study of nab ... The overall goals of this study are to ...
... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also ... factors and spared pathophysiological effects despite their genetic risk.
In this study, some of the patient's T cells will be removed from their blood. ... Factors. Rochester, Minn ... Randomized Phase II/III Trial of Adjuvant ...
Godby, M.D.. Hematologist. Rochester, MN. مناطق التركيز: Blood transfusion, Bone marrow biopsy and aspiration, Immunosuppressive drug therapy, Growth factor ...
The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
There is very little data exists in regards to patient clinical characteristics, risk factors, treatment and outcomes. Our objective is to prospectively ...
... blood samples for future DNA/RNA sequencing , and to collect patient urine samples for future prostate cancer related biomarker detection and DNA/RNA sequencing ...
Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.